cirrhosis

75
CIRRHOSIS Nurfarhana binti Lazim Nazihah bt Mohamad Siti Aisyah binti Mat Jusoh Noor Azira binti Sharif Siti Hamidah binti Mahbud MED STUDENT OF UniSZA

Upload: hamidah-harith

Post on 07-May-2015

747 views

Category:

Health & Medicine


2 download

DESCRIPTION

simple about cirrhosis by medical students UniSZA. lets learn together

TRANSCRIPT

Page 1: Cirrhosis

CIRRHOSIS

Nurfarhana binti LazimNazihah bt Mohamad

Siti Aisyah binti Mat JusohNoor Azira binti Sharif

Siti Hamidah binti Mahbud

MED STUDENT OF UniSZA

Page 2: Cirrhosis
Page 3: Cirrhosis

LIVER• the second largest organ and the largest gland• predominantly occupies the right

hypochondrium but the left lobe extends to the epigastrium

• shape: prism or wedge• is pinkish brown in color, with a soft

consistency, and is highly vascular and easily friable

Page 4: Cirrhosis
Page 5: Cirrhosis

• covered by peritoneum with the exception of the ‘bare area’.

• the upper surface of the liver is percussed at the level of the fifth intercostal space

• the anterior surface is separated from the inferior (visceral) surface by a sharp anterior (inferior) border that is clinically palpable.

Page 6: Cirrhosis

Segmental Division

Anatomical division

Falciform ligament (ant)

Ligamentum venosum (post)

Physiological division

Fossa for gall bladder

Fossa for IVC

divided by

Page 7: Cirrhosis

• The liver has a unique dual blood supply (about 1500 mL/min) both from the proper hepatic artery (20-40%) and from the portal vein (60-80%)

Page 8: Cirrhosis
Page 9: Cirrhosis
Page 10: Cirrhosis
Page 11: Cirrhosis
Page 12: Cirrhosis

• formed of hexagonal lobules with a central vein in the center and portal triad at the corners.

• plates are separated by blood sinusoids lined by endothelium and contain Von-Kupffor cells.

• hepatocytes at the periphery of the lobules facing portal tracts are called the limiting plates.

Page 13: Cirrhosis
Page 14: Cirrhosis
Page 15: Cirrhosis
Page 16: Cirrhosis

Porto-systemic anastomosis

Gastro-esophageal

junction

Left gastri

c vein

Azygos

vein

Anal area

Superior

rectal vein

Middle &

inferior

rectal vein

Around umbilicus

Para-umbil

ical vein

Veins of

anterior

abdominal wall

Page 17: Cirrhosis

FUNCTIONS OF THE LIVER

Physiology of the liver

Page 18: Cirrhosis

PROTEIN METABOLISMsynthesis and storage

• the liver is the principal site of synthesis of all circullating protein apart

from γ-globulin which are produced in the reticulo endothelial system.

• the liver receives amino acid from the intestine and muscles and, by

controlling the rate of gluconeogenesis and transamination, regulate

levels in the plasma.

•Plasma cotains 60-80 g/L of protein, mainly in the form of albumin,

globulin and fibrinogen

Page 19: Cirrhosis

• albumin has a half life of 16-24 days, and 10-12 g are synthetized daily.• its main function are: - to maintain the intravascular oncotic ( colloid osmotic) pressure - to transport water- insoluble substances such as

*bilirubin,*hormones*fatty acid*drugs

• reduced synthesis of albumin over prolonged periods hypoalbuminaemia ( in chronic liver disease and malnutrition)

•Hypoalbuminaemia also found in : - hypercatabolic states ( trauma with sepsis)

- diseases where there is an excessive loss ( nephrotic syndrome, protein losing enteropathy )

Page 20: Cirrhosis

• transport or carrier proteins such as transferrin and caeruloplasmin, acute phase and other proteins such as:

- α1- antitrypsin- α- fetoprotein

are also produced in liver.• the liver also synthesized all factors involved in coagulation ( apart from one-third of factor VII ) that is :

- fibrinogen- prothrombin- factors V,VII,IX,X and XII- protein C and S- antithrombin- complement system

• the liver stores:- large amounts of vitamins, particularly A, D and B12- lesser amounts of others vitamin K and folate- also minerals ( iron in ferritinhaemosiderin and copper

Page 21: Cirrhosis

Degradation (nitrogen excretion)

This is the major pathway for the elimination of nitrogenous waste

Failure of this process occurs in severe liver disease

Page 22: Cirrhosis

CARBOHYDRATE METABOLISMMajor function of the liver :- Glucose homeostasis- Maintenance of blood sugar Liver stores – 80 g of glycogen

Immediate fasting state Prolonged starvation

• blood glucose mantained by glycogenolysis or by gluconeogenesis

• source of gluconeogenesis - lactate - pyruvate - amino acids from muscle (mainly alanine and glutamine) - glycerol from lipolysis of fat stores

Ketone bodies and fatty acids

Page 23: Cirrhosis

LIPID METABOLISM

Fats are insoluble in water and are transported in the plasma as protein lipid complexes ( lipo proteins)

It synthesizes :•VLDLs•HDLs•LCAT• IDLs• LDLs • triglycerides ( mainly of dietary origin)• Cholesterol ( dietary origin )

The liver has a major role in the metabolism of lipoproteins

Page 24: Cirrhosis

FORMATION OF BILE

• Bile secretion and bile acid metabolism

bile consist of water , electrolytesbile acids, cholesterol,phospholipids and conjugated bilirubin

• bilirubin metabolism

Bilirubin is produced mainly from the breakdown of mature red cells in the kuffer cells of the liner and in the reticuloendothelial system

Page 25: Cirrhosis

HORMONE AND DRUG INACTIVATION

•The liver catabolizes hormones such as:

- insulin - glucagon- oestrogens- growth hormone- glucocorticoids - parathyroid homones

• it is the major site for the metabolism of drugs and alcohol

Page 26: Cirrhosis

IMMUNOLOGICAL FUNCTION

The liver act as ‘sieve’ for the bacterial and other antigens carried to it via

the portal tract from the gastrointestinal tract

- kuffer cell ( macrophage, sp. Memb. Receptor for ligands ag

degrade without ab )

- the reticulo endothelial sys. tissue repair

- T and B lymphocyte interaction

- cytotoxic activity in disease processes

Page 27: Cirrhosis

Liver CirrhosisBY: SITI AISYAH MAT JUSOH

Page 28: Cirrhosis

cirrhosis

• Consequence of chronic liver disease characterized by replacement of liver tissue by diffuse hepatic fibrosis, scar tissue and regenerative nodules

• The liver architecture is diffusely abnormal and this interferes with liver blood flow and function

• Occur at any age, has significant morbidity and is an important cause of hepatic death

Page 29: Cirrhosis
Page 30: Cirrhosis

Epidemiology• According to World Health Organization (WHO) every year

3-4 million people are infected by Hepatitis C. About 150 million people are chronically infected and at risk of developing liver cirrhosis and/or liver cancer. And more than 350,000 people die every year from Hepatitis C-related liver disease.

• In Malaysia, according to the Malaysian Liver Foundation (MLF), an estimated 2.5 million people suffer from chronic Hepatitis, and this doesn’t include other serious liver afflicted diseases such as Jaundice, Alcoholic liver disease (ALD), Non-Alcoholic fatty liver disease (NAFLD) and Liver Cirrhosis brought about by toxins from everyday products and alcohol consumption.

Page 31: Cirrhosis

• Indian had a high prevalence of alcohol-associated chronic liver disease

• Hepatitis B was the predominant etiology in Malay and Chinese compared to Indians

• Hepatitis C cirrhosis was highest in Malay

University of Malaya Medical Centre(2006)

Page 32: Cirrhosis

pathogenesis

• Cardinal features of cirrhosis:– an increase in fibrous tissue – progressive and widespread death of liver cells– inflammation leading to loss of the normal liver

architecture

Page 33: Cirrhosis
Page 34: Cirrhosis

• Following liver injury, stellate cells in space of Disse are activated by cytokines and their receptors, reactive oxygen intermediates and other paracrine and autocrine signals produced by Kupffer cell, activated platelets and hepatocytes

• This transform stellate cell into myofibroblast-like cell, capable of producing collagen, pro-inflammatory cytokines and other mediators which promote hepatocyte damage and cause tissue fibrosis

• The progression of liver injury to cirrhosis may occur over weeks to years

Page 35: Cirrhosis

• Destruction of liver architecture causes distortion and loss of normal hepatic vasculature with the development of portosystemic vascular shunts and the formation of nodules

• It evolves slowly over years to decades and normally continues to progress even after removal of the aetiological agent

Page 36: Cirrhosis

• Can be classified histologically into two types:

– Micronodular cirrhosis

– Macronodular cirrhosis

Page 37: Cirrhosis

Micronodular cirrhosis

characterised by small nodules about <3mm in diameter and seen in alcoholic or biliary tract disease

Page 38: Cirrhosis

Macronodular cirrhosis

characterised by larger nodules of various sizes and normal acini may be seen within larger nodules, areas of previous collapse of the liver architecture are evidenced by larger fibrous scars. This types often seen following chronic viral hepatitis

Page 39: Cirrhosis

EtiologyCommon Others

• Alcohol• Hepatitis B• Hepatitis C• Non-alcoholic fatty liver disease

• Biliary cirrhosis: primary or secondary

• Autoimmune hepatitis• Hereditary Haemochromatosis• Hepatic venous congestion• Budd Chiari Syndrome• Wilson’s Disease• Drugs• Alpha 1 Antitrypsin deficiency• Cystic Fibrosis• Galactosemia• Glycogen storage disease• Veno-occlusive disease• Idiopathic (Cryptogenic)

Page 40: Cirrhosis

Long-term heavy drinking of alcohol– Estimated that the development of cirrhosis requires, on

average, the ingestion of 80 grams of ethanol daily for 10 to 20 years

– This corresponds to approximately one liter of wine, eight standard sized beers, or one half pint of hard liquor each day

– Chronic consumption of alcohol secretion of pro-inflammatory cytokines (TNF-alpha, IL6 and IL8), oxidative stress, lipid peroxidation, and acetaldehyde toxicity inflammation, apoptosis and eventually fibrosis of liver cells

– females are twice as susceptible to alcohol-related liver disease, with shorter durations and doses of chronic consumption

Page 41: Cirrhosis

Chronic viral hepatitis type B, C and Do Infection with the hepatitis C virus causes

inflammation of the liver and a variable grade of damage to the organ that over several decades can lead to cirrhosis the most common reason for liver transplant

– Hepatitis D is dependent on the presence of hepatitis B and accelerates cirrhosis in co-infection

Page 42: Cirrhosis

• Non-alcoholic steatohepatitis– fat builds up in the liver and eventually causes scar tissue– associated with diabetes, protein malnutrition, obesity,

coronary artery disease, and treatment with corticosteroid medications

• Primary biliary cirrhosis– more common in women– an autoimmune disease of the liver– slow progressive destruction of the small bile ducts of

the liver, with the intralobular ducts (Canals of Hering) affected early in the disease. When these ducts are damaged, bile builds up in the liver (cholestasis) and over time damages the tissue

Page 43: Cirrhosis

• Autoimmune chronic active hepatitis– uncommon condition that results in the body's

immune system attacking and destroying liver cells.

– abnormal immune response results in inflammation of the liver

• Haemochromatosis– too much iron is absorbed by the body and the

excess is deposited in the liver and cause liver to enlarge and becomes damaged, 

– Causes: hereditary haemochromatosis(HHC), a genetic disorder, and transfusional iron overload, which can result from repeated blood transfusion.

Page 44: Cirrhosis

• Wilson’s disease– an autosomal recessive genetic disorder in which

copper accumulates in tissues; this manifests as neurological or psychiatric symptoms and liver disease

– When the amount of copper in the liver overwhelms the proteins that normally bind it, it causes oxidative damage through a process known as Fenton chemistry; this damage eventually leads to chronic active hepatitis, fibrosis (deposition of connective tissue) and cirrhosis

Page 45: Cirrhosis

• Alpha-1 antitrypsin deficiency– Alpha-1 antitrypsin (A1AT) is a protein produced by the

liver that protects the lungs – a genetic disorder that causes defective production

of alpha 1-antitrypsin(A1AT), leading to decreased A1AT activity in the blood and lungs, and deposition of excessive abnormal A1AT protein in liver cells.

– Because A1AT is expressed in the liver, certain mutations in the gene encoding the protein can cause misfolding and impaired secretion, which can lead to liver cirrhosis

• Galactosaemia– the enzymes needed for further metabolism of galactose

are severely diminished or missing entirely, leading to toxic levels of galactose 1-phosphate in various tissues resulting in hepatomegaly and cirrhosis

Page 46: Cirrhosis

Symptom of liver disease

Signs of chronic liver disease

Complication of cirrhosis

Page 47: Cirrhosis

Symptoms of liver disease

Acute liver disease

Chronic liver disease

Page 48: Cirrhosis

Symptoms Acute liver disease

• Malaise• Anorexia • Fever• Jaundice

Page 49: Cirrhosis

Symptoms chronic liver disease

• right hypochondrial pain• abdominal distension• ankle swelling• haematemesis and melaena• pruritus• breast swelling (gynaecomastia), loss of libido and

amenorrhoea• confusion and drowsiness

Page 50: Cirrhosis

Signs of chronic liver disease

Page 51: Cirrhosis

INVESTIGATION OF CIRRHOSIS

Siti hamidah bt mahbud

Page 52: Cirrhosis

To assess severityLiver function test. Serum albumin and prothrombin time(marker for synthetic function of liver)•the outlook is poor with an albumin level below 28 g/L. •prothrombin time ^ = ^ severity of the liver disease

Page 53: Cirrhosis
Page 54: Cirrhosis

Liver biochemistry.Aminotransferases (ALT and AST) – present in hepatocytes and leak to blood when cell damage.

• AST(mitochondrial enzyme: present in heart ,muscle ,kidney & brain)= ^ in hepatic necrosis, MI, muscle injury, congestive cardiac failure.• ALT (cytosomal enzyme: present in liver) = ^ in lever disease.

Alkaline phosphate (ALP) –present in canalicular & sinusoidal membranes of the liver, bone, intestine, placenta.• ^ in cholestasis, may also ^ in metastases to liver and cirrhosis

Page 55: Cirrhosis

can be normal, depending on the severity of cirrhosis. In most cases there is at least a slight elevation in the serum ALP and serum aminotransferases.

Bilirubin = ^ in liver disease

Page 56: Cirrhosis

Serum electrolytes.low sodium indicates severe liver disease due to a defect in free water clearance or to excess diuretic therapy.

Serum creatinine. An elevated concentration > 130 μmol/L is a marker of worse prognosis.

Page 57: Cirrhosis

Type of cirrhosis

This can be determined by: ■ viral markers

■ serum autoantibodiesAnti-mitochondrial antibody (AMA) = primary biliary cirrhosis

■ serum immunoglobulins^ igM = primary biliary cirrhosis.

Page 58: Cirrhosis

■ iron indices and ferritin

■ copper & α1-antitrypsin

Serum copper and serum α1-antitrypsin should always be measured in young cirrhotics. Total iron-binding capacity (TIBC) and ferritin should be measured to exclude hereditary haemochromatosis; genetic markers are also available

Page 59: Cirrhosis

ImagingUltrasound examination. can demonstrate changes in size and shape of the liver. Fatty change and fibrosis produce a diffuse increased echogenicity. In established cirrhosis there may be marginal nodularity of the liver surface and distortion of the arterial vascular architecture.

Page 60: Cirrhosis

CT scan CT scan showing an irregular lobulated liver. Thereis splenomegaly and enlargement of collateral vesselsbeneath the anterior abdominal wall (arrows) as a result of portal hypertension.

Page 61: Cirrhosis

Endoscopy performed for the detection and Treatment of varices, and portal hypertensive gastropathy..

MRI scan. This is useful in the diagnosis of benign tumours such as haemangiomas.

Liver biopsynecessary to confirm the severity and type of liver disease.

Page 62: Cirrhosis

Complication & effect of cirrhosis

• Portal hypertension and gastrointestinal haemorrhage

• Ascites• Portosystemic

encephalopathy

• Hepatorenal syndrome • Hepatocellular

carcinoma• Bacteraemias,

infections• Malnutrition

Page 63: Cirrhosis

Portal hypertension

• Elevation of hepatic venous pressure gradient to > 5mm Hg.

• It is caused by combination of 2 simultaneously occuring hemodynamic processes :

1. Increased intrahepatic resistance to passage of blood flow through liver

2. Increased splanchnic blood flow secondary to vasodilation

Page 64: Cirrhosis

Portal hypertension

Page 65: Cirrhosis
Page 66: Cirrhosis

Ascitis

• Accumulation of fluid within the peritoneal cavity

• Most common complication of cirrhosis • Two-year survival of patients with ascites is

approximately 50 percent

Page 67: Cirrhosis

Ascitis • Assessment of ascites

– Grading • Grade 1 — mild;

Detectable only by US• Grade 2 — moderate;

Moderate symmetrical distension of the abdomen

• Grade 3 — large or gross asites with marked abdominal distension

• Therapy: diuretics paracentesis

Page 68: Cirrhosis

Portosystemic encephalopathy

• Toxic substances (ammonia) bypass the liver via collaterals and gain access to the brain

• Symptoms: lethargy mild confusion anorexia reversal of sleep pattern disorientation coma

Page 69: Cirrhosis

Hapatorenal syndrome

• acute renal failure coupled with advanced hepatic disease (due to cirrhosis or less often metastatic tumor or severe alcoholic hepatitis)

• characterized by:– Oliguria– benign urine sediment– very low rate of sodium excretion– progressive rise in the plasma creatinine concentration

Page 70: Cirrhosis

Hepatorenal syndrome

• Reduction in GFR often clinically masked• Prognosis is poor unless hepatic function

improves• Nephrotoxic agents and overdiuresis can

precipitate HRS

Page 71: Cirrhosis

Management of cirrhosis

Page 72: Cirrhosis

• Treatment options for cirrhosis depend on the cause and the level of liver damage. The goals of treatment are to prevent further liver damage and reduce complications.

• When cirrhosis cannot be treated, the liver will not be able to work and a liver transplant may be needed

Page 73: Cirrhosis
Page 74: Cirrhosis

way to manage cirrhosis• Maintain a healthy lifestyle (eat a healthy diet and

exercise regularly)• Limit salt in your diet to prevent or reduce fluid

build up• Avoid raw shellfish• Stop drinking alcohol• Talk to your doctor about hepatitis A and hepatitis

B vaccinations• Do not share needles, razors, toothbrushes or

other personal items with others

Page 75: Cirrhosis

REFERENCESBOOK• Kumar & Clarks; Clinical Medicine; 7th EditionWEB1. Cirrhosis: Diagnosis, Management, and

Prevention ; American family physician By : S. PAUL STARR, MD, and DANIEL RAINES, MD, Louisiana State University

Health Sciences Center School of Medicine at New Orleans, New Orleans, Louisiana

2. Cirrhosis ; American liver foundation